Related Experiment Video
Updated: Jul 19, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Diversity considerations in HIV-1 vaccine selection
Brian Gaschen1, Jesse Taylor, Karina Yusim
1Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Human immunodeficiency virus-type 1 (HIV-1) diversity complicates AIDS vaccine development. Using consensus or ancestor sequences in vaccine design could reduce genetic differences and enhance protection against circulating viruses.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Human immunodeficiency virus-type 1 (HIV-1) exhibits extraordinary global genetic diversity.
- This variability presents a significant challenge for the development of effective AIDS vaccines.
- Current vaccine candidates are based on specific isolates, aiming for cross-reactivity against diverse circulating strains.
Purpose of the Study:
- To address the challenge of HIV-1 diversity in AIDS vaccine development.
- To explore alternative strategies beyond country-specific vaccines.
- To propose a method for minimizing genetic differences between vaccine candidates and circulating HIV-1 strains.
Main Methods:
- Analysis of HIV-1 genetic diversity and evolutionary relationships.
- Evaluation of the potential of consensus or ancestor sequences for vaccine design.
- Comparison of evolutionary relationships versus regional considerations for vaccine strategies.
Main Results:
- HIV-1 envelope proteins can differ by over 30% in amino acid sequences, highlighting significant diversity.
- Evolutionary relationships may offer a more effective approach to vaccine design than geographical considerations.
- Utilizing consensus or ancestor sequences can potentially halve the genetic differences between vaccine strains and contemporary isolates.
Conclusions:
- The high diversity of HIV-1 necessitates innovative approaches for AIDS vaccine development.
- Consensus or ancestor sequences represent a promising strategy to broaden vaccine efficacy.
- Minimizing genetic distance through sequence-based design could improve cross-protection against diverse HIV-1 strains.
More Related Videos
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Bioequivalence studies: Biowaivers